期刊文献+

正常范围甲状腺激素水平与冠状动脉Gensini评分的相关性分析 被引量:7

Relationship between Normal Thyroid Hormone Levels with Gensini Coronary Scoring System
下载PDF
导出
摘要 目的探讨甲状腺功能正常的冠心病患者甲状腺激素水平与冠状动脉Gensini评分的关系。方法选取231例均行冠状动脉造影且确诊为冠心病患者,同时测定总三碘甲状腺原氨酸(TT3)、总甲状腺素(TT4)、游离甲状腺素(FT4)、游离三碘甲状腺原氨酸(FT3)和促甲状腺激素(TSH),其值均在正常范围,同时通过造影结果计算Gensini积分,依据Gensini积分分为4组并进行积分与各种检验指标的相关分析。结果 4组不同病变程度的冠心病患者TT3、TT4、FT4、TSH、CHO、TG的差异均无统计学意义(P>0.05),FT3、HDL-C随着冠脉病变程度的增加而降低(P<0.01),年龄、LDL-C随着冠脉病变程度的增加而增加,且有统计学意义(P<0.05)。Gensini积分与FT3、HDL-C呈直线负相关,与年龄、LDL-C呈正相关。年龄、FT3、HDL-C、LDL-C与Gensini积分呈独立相关。结论在甲状腺功能正常时,FT3可作为冠心病患者病变程度的独立危险因素。 Objective To study the correlation between normal level of thyroid hormone and gensini coronary scor-ing system. Methods Coronary heart disease patient who were treated with Cardio-angiography (CAG) (n=231) were divid-ed into 4 groups based on gensini coronary score. All the patients were examined with indexes include total triiodothyronine (TT3), total thyronine(TT4), free thyronine(FT4), free triiodothyronine (FT3), thyroid stimulating hormone (TSH). And correla-tion between thyroid hormone level and gensini coronary scoring system was studied by Spearman correlation analysis and Multiple regression analysis. Results No significant difference was found in the levels of TT3, TT4, FT4, Cholesterol(CHO) and Triglyceride(TG) between the all 4 groups (P〉0.05). FT3 and HDL-C decreased with the increase of extent of coronary artery lesions(P〈0.01), and AGE and LDL-C raised with the coronary artery lesions extent (P〈0.05). Gensini coronary scoring system was linearly negatively correlated with FT3, HDL-C and positively correlated with age and LDL-C. Age, FT3,HDL-C,LDL-C was independently correlated to Gensini score. Conclusion The lower level of FT3 is an indepen-dent risk factor for CHD.
出处 《天津医药》 CAS 北大核心 2014年第8期793-795,804,共4页 Tianjin Medical Journal
基金 天津市科技计划项目(12ZCZDSY03200)
关键词 甲状腺素 三碘甲状腺原氨酸 冠心病 GENSINI评分 thyroxine triiodothyronine coronary disease gensini coronary scoring system
  • 相关文献

参考文献14

  • 1Biondi B. Invited commentary: Cardiovascular mortality in subclini- cal hyperthyroidism: an ongoing dilemma[J]. Eur J Endoerinol, 2010, 162(3): 587-589. doi: 10.1530/EJE-09-1095.
  • 2Friberg L, Werner S, Eggertsen G. Rapid downregulation of thyroid- hormone profile of asymptomatie or mildly symptomatic idiopathic left ventricular dysfunction[J]. J Card Fail, 2006, 12: 520-526. doi: 10.1001/archinte.162.12.1388.
  • 3Razvi S, Weaver JU, Butler TJ, et al. Levothyroxine treatment of subclinical hypothyroidism, fatal and nonfatal cardiovascular events, and mortality[J]. Arch Intern Med, 2012, 172(10): 811-817. doi: 10.1001/archinternmed.2012.1159.
  • 4McQuade C, Skugor M, Brennan DM, et al. Hypothyroidism and moderate subclinical hypothyroidism are associated with increased all-cause mortality independent of coronary heart disease risk fac-tors: PreCIS database study[J]. Thyroid, 2011, 21(8):837-843. doi: 10.1089/thy.2010.0298.
  • 5赵翠,曹路,丛洪良.甲状腺功能正常者甲状腺激素水平与冠心病发病的相关性分析[J].中华老年心脑血管病杂志,2012,14(4):358-360. 被引量:7
  • 6安乐农,师会利.冠心病患者甲状腺功能的检测分析[J].放射免疫学杂志,2005,18(2):131-131. 被引量:5
  • 7Biondi B, Klein I. Hypothyroidism as a risk factor for cardiovascular disease[J]. Endocrine, 2004, 24(1): 1-13. doi:10.1385/ENDO:24:l: 001.
  • 8Monzani F, Caraccio N, Kozakowa M, et al. Effect of levothyroxine replacement on lipid profile and intima-media thickness in subclin- ical hypothyroidism: adouble-blind, placebo-controlled study[J].J Clin Endocfinol Metab, 2004, 89(5): 2099-2106. doi:10.1210/ je.2003-031669.
  • 9Singh S, Duggal J, Molnar J, et al. Impact of subclinical thyroid dis- orders on coronary heart disease, cardiovascUlar and all-cause mot-tality: a meta-analysis[J]. Int J Cardiol, 2008, 125(1): 41-48. doi: 10.1016/j.ijcard.2007.02.027.
  • 10Auer J, Berent R, Weber T, et al. Thyroid function is associated with presence and severity of coronary atherosclerosis[J]. Clin Cardi- ol, 2003, 26(12): 569-573. doi: 10.1002/clc.4960261205.

二级参考文献16

  • 1Klein I,Ojamaa K. Thyroid hormone and cardiovascular system[J].New England Journal of Medicine,2001.501-509.
  • 2Biondi B. Invited Commentary:Cardiovascular mortality in subclinical hyperthyroidism:An ongoing dilemma[J].European Journal of Endocrinology,2010.587-589.
  • 3Fazxio S,Palmiefi EA,Biondi B. Effects of thyroid hormone on the cardiovascular system[J].Reeent Prog Horm Res,2004.31-50.
  • 4Mc Quade C,Skugor M,Brennan DM. Hypothyriodism and moderate subclinical hypothyroidism are associated with increased all cause mortality independent of coronary heart disease risk factors:A PreCIS database study[J].Thyroid:Official Journal of the American Thyroid Association,2011.837-843.
  • 5Singh S,Duggal J,Molnar J. Impact of subclinical throid disorders on coronary heart disease,cardiovascular and allcause mortality:A meta analysis[J].International Journal of Cardiology,2008.41-48.
  • 6June CH,Rhee EJ,Shin HS. Higher serum free thyroxine levels are associated with coronary artery disease[J].Endocrine Journal,2008.819-826.
  • 7Peter A,Ehlers M,Blank B. Excess triiodothyronine as a risk factor of coronary events[J].Archives of Internal Medicine,2000.1993-1999.
  • 8Auer J,Berent R,Weber T. Thyroid function is associated with presence and severity of coronary atherosclerosis[J].Clinical Cardiology,2003.569-573.
  • 9Coceani M,Iervasi G,Pingitore A. Thyroid hormone and coronary artery disease:From clinical correlations to prognostic implications[J].Clinical Cardiology,2009.380-385.
  • 10Cerillo AG,Bevilacqua S,Storti S. Free triiodotyhronine:A novel predictor of postoperative atrial fibrillation[J].European Journal of Cardio-Thoracic Surgery,2003.487-492.

共引文献10

同被引文献30

引证文献7

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部